Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 125 participants.

Also called NCT07757464

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Shifa International Hospital (from the registry)
Registry
  • NCT NCT07757464
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07757464. Randomized; single masking; primary purpose treatment. Start 2026-08-10 (actual); primary completion 2027-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes
Acronym
PREVENT-SIH
Condition
Diabetes Mellitus, Type 2
Condition
Hyperglycemia Due to Type 2 Diabetes Mellitus
Condition
Osteoarthritis, Knee
Intervention (Drug)
Insulin Isophane Human, NPH, Pre-emptive Algorithm
Intervention (Drug)
Triamcinolone Acetonide Knee Injection
Lead sponsor
Shifa International Hospital (class: other)
Collaborator
Al Ain University (class: other)

Record details

Record id
cardio:ct-nct07757464
Content hash
2283d8090c4c3953be43a486ed5c6fd345ed3cafe7013c166a7532caed6b0553